Galapagos NV is taking decisive steps to reinforce its leadership and board, aiming to drive growth and innovation in its therapeutic areas.

Galapagos NV has announced a strategic pivot, including leadership changes and a re-evaluation of its separation plan, as the biotech company navigates financial challenges and explores new business avenues.

Galapagos NV has announced a strategic shift and leadership changes, including a new CEO, as the biotech company re-evaluates its separation plans and explores new opportunities in the biotechnology landscape.